Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymalfasin with Regorafenib and Tislelizumab in Advanced PMMR/MSS Colorectal Cancer
NCT06829355Phase 2Recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin alpha 1 in colorectal cancer (CRC), sponsored by Beijing Friendship Hospital. Started Feb 2025; status: recruiting.
02
Drugs
thymosin alpha 1
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06829355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06829355.